WHO 2015 Guidelines to Recommend Treatment for All HIV-Positive People
July 19, 2015
On 18 July 2015, at the IAS 2015 pre-conference UN 90-90-90 Target workshop: lessons from the field, Gottfried Hirnschall, Director of HIV Department at World Health Organization (WHO) provided a "sneak preview" of the in-the-process-of-being-updated 2015 consolidated guidelines.
The headline is: following the START results, WHO will recommend ART for everyone with HIV.
Also important is that dolutegravir and efavirenz 400 mg will be recommended as alternatives first-line options to using efavirenz 600 mg.
This is good news.
Expect more sneak previews of the guidelines -- details are promised at IAS.
Hirnschall G. WHO Global HIV Guidelines: How innovations in policy and implementation can pave the way to achieving 90-90-90. UN 90-90-90 Target workshop: lessons from the field.18 July 2015. Vancouver, BC, Canada.
IAS 2015 to Feature Landmark Research Covering the Most Critical Areas in the Global Response to HIV
This article was provided by HIV i-Base. It is a part of the publication HIV Treatment Bulletin. Visit HIV i-Base's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.